Literature DB >> 4266829

Cervical cord compression in mucopolysaccharidosis.

P Kennedy, M Swash, M F Dean.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4266829     DOI： 10.1111/j.1469-8749.1973.tb15160.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN： 0012-1622            Impact factor:   5.449


× No keyword cloud information.
  8 in total

1.  Immune response to intrathecal enzyme replacement therapy in mucopolysaccharidosis I patients.

Authors:  Moin Vera; Steven Le; Shih-Hsin Kan; Hermes Garban; David Naylor; Anton Mlikotic; Ilkka Kaitila; Paul Harmatz; Agnes Chen; Patricia Dickson
Journal:  Pediatr Res       Date:  2013-09-03       Impact factor: 3.756

2.  Computed tomography studies on patients with mucopolysaccharidoses.

Authors:  R W Watts; E Spellacy; B E Kendall; G du Boulay; D A Gibbs
Journal:  Neuroradiology       Date:  1981-02       Impact factor: 2.804

Review 3.  Spinal meningeal malformations in children (without meningoceles or meningomyeloceles).

Authors:  J Richaud
Journal:  Childs Nerv Syst       Date:  1988-04       Impact factor: 1.475

4.  Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I.

Authors:  Patricia I Dickson; Stephen Hanson; Michael F McEntee; Charles H Vite; Carole A Vogler; Anton Mlikotic; Agnes H Chen; Katherine P Ponder; Mark E Haskins; Brigette L Tippin; Steven Q Le; Merry B Passage; Catalina Guerra; Ashley Dierenfeld; Jackie Jens; Elizabeth Snella; Shih-Hsin Kan; N Matthew Ellinwood
Journal:  Mol Genet Metab       Date:  2010-07-23       Impact factor: 4.797

5.  Hydrocephalus and pseudotumour cerebri in the mucopolysaccharidoses.

Authors:  M Sheridan; I Johnston
Journal:  Childs Nerv Syst       Date:  1994-04       Impact factor: 1.475

6.  Targeting of the CNS in MPS-IH using a nonviral transferrin-alpha-L-iduronidase fusion gene product.

Authors:  Mark J Osborn; Ron T McElmurry; Brandon Peacock; Jakub Tolar; Bruce R Blazar
Journal:  Mol Ther       Date:  2008-06-03       Impact factor: 11.454

7.  Neurogenic bladder in Hunter's syndrome.

Authors:  K Koyama; Y Moda; A Sone; H Tanaka; Y Hino
Journal:  J Med Genet       Date:  1994-03       Impact factor: 6.318

8.  alpha-L-iduronidase therapy for mucopolysaccharidosis type I.

Authors:  Jakub Tolar; Paul J Orchard
Journal:  Biologics       Date:  2008-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.